Apollon Formularies (AQSE:APOL) Operating Cash Flow per Share : £0.00 (TTM As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Apollon Formularies Operating Cash Flow per Share?

Apollon Formularies's operating cash flow per share for the six months ended in Jun. 2023 was £0.00. Apollon Formularies's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2023 was £0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 37.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Apollon Formularies's Operating Cash Flow per Share or its related term are showing as below:

AQSE:APOL' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 37.9 Med: 37.9 Max: 37.9
Current: 37.9

During the past 11 years, Apollon Formularies's highest 3-Year average Operating Cash Flow per Share Growth Rate was 37.90% per year. The lowest was 37.90% per year. And the median was 37.90% per year.

AQSE:APOL's 3-Year OCF Growth Rate is ranked better than
82.52% of 801 companies
in the Drug Manufacturers industry
Industry Median: 7.5 vs AQSE:APOL: 37.90

Apollon Formularies Operating Cash Flow per Share Historical Data

The historical data trend for Apollon Formularies's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollon Formularies Operating Cash Flow per Share Chart

Apollon Formularies Annual Data

Trend

Jun10

Jun11

Dec12

Dec13

Dec14

Dec17

Dec18

Dec19

Dec20

Dec21

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.03

-0.01

Apollon Formularies Semi-Annual Data
	Jun11	Jun12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Jun23
Operating Cash Flow per Share	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of Apollon Formularies's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Apollon Formularies's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apollon Formularies's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Apollon Formularies's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Apollon Formularies's Price-to-Operating-Cash-Flow falls into.

Apollon Formularies Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Apollon Formularies's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2021 is calculated as

Operating Cash Flow per Share (A: Dec. 2021 )	=	Cash Flow from Operations (A: Dec. 2021 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2021 )
	=	-3.106	/	548.103
	=	-0.01

Apollon Formularies's Operating Cash Flow per Share for the quarter that ended in Dec. 2021 is calculated as

Operating Cash Flow per Share (Q: Jun. 2023 )	=	Cash Flow from Operations (Q: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Jun. 2023 )
	=	-0.031	/	771.191
	=	-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00

Apollon Formularies Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Apollon Formularies's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollon Formularies (AQSE:APOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apollon Formularies PLC (AQSE:APOL) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Hope Street, Quayside House, Castletown, IMN, IM9 1AS

Website

https://www.apollon.org.uk

Apollon Formularies PLC is a London, England and Jamaican based medical cannabis pharmaceutical company specialising in research and treatment of patients with cancer and chronic pain. It is engaged in investing by seeking to acquire a direct and/or indirect interest in projects and assets in the agriculture and logistics sectors and the medicinal cannabis sector. The company focus on opportunities in Africa and Europe. It has created proprietary hybrid medical cannabis pharmaceutical strains, technology, formulations, and treatment products.